Logo

PharmaShots' Most Read News of 2018

Share this

PharmaShots' Most Read News of 2018

PharmaShots' Most Read News of 2018 | Top 10 Pharma News of 2018 

1. Celgene to Acquire Juno for its Cellular Immunotherapy & Hematology Portfolio

Published: 22 Jan, 2018 | Tags: Celgene,  Acquire, Juno, Cellular, Immunotherapy, Hematology Portfolio

2.  Sanofi to Acquire Bioverativ for its Hemophilia Products

Published: 22 Jan, 2018 | Tags: Sanofi, Acquire, Bioverativ, Treat, Hemophilia, $11.6B

3. FDA Refuses Celgene for Filling Ozanimod's NDA for Relapsing Multiple Sclerosis

Published: 27 Feb, 2018 | Tags: FDA, Refuse, Celgene, Filling, Ozanimod, NDA, Treatment, Relapsing, Multiple Sclerosis

4. GSK to Acquire 36.5% Stake in Consumer Healthcare Joint Venture, Formed with Novartis

Published: 14 Apr, 2018 | Tags: GSK, Acquire, 36.5%, Stake, Consumer, Healthcare, Joint Venture, Established, Novartis

5. Novartis to Acquire AveXis for its Gene Therapy Clinical Candidates

Published: 22 Apr, 2018 | Tags: Novartis, Acquire, AveXis, Gene Therapy, Clinical, Candidates, 8.7B

6. Lilly Reports Negative Results of Solanezumab in P-III EXPEDITION Studies in Patients with Alzheimer Disease

Published: 23 Jun, 2018 | Tags: Lilly, Report, Negative, Results, Solanezum, P-III, EXPEDITION Studies, Patients, Alzheimer, Disease

7. Novo Nordisk, Genentech and Sanofi to Cut Off Jobs in 2018

Published: 07 Sept, 2018 | Tags: 2018, cut off, Genentech, jobs, Novo Nordisk, Sanofi

8. Pfizer Announce to Raise Prices of its 41 Drugs in the US, in 2019

Published: 07 Sept, 2018 | Tags: FDA, Refuse, Celgene, Ozanimod, NDA, Treatment, Relapsing, Multiple, Sclerosis

9. Leading Pharma Companies Appointed Their New CEOs in 2018

Published: 06 Oct, 2018 | Tags: Top, Pharma, Companies, Appointed, Their, New, CEOs, 2018, Pfizer, Novartis, Gilead

10. GSK to Collaborate with Pfizer to Build a Consumer Healthcare Joint Venture

Published: 19 Dec, 2018 | Tags: GSK, Collaborate, Pfizer, Build, Consumer, Healthcare, Joint Venture, 68%


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions